We are live on ! Find out more
NI

Noked Israel Portfolio holdings

AUM $677M
1-Year Est. Return 69.37%
This Fund
S&P 500
This Quarter Est. Return
+32.73%
1 Year Est. Return
+69.37%
3 Year Est. Return
+201.74%
5 Year Est. Return
+303.34%
10 Year Est. Return
–
AUM
$81.6M
AUM Growth
-$14.3M
Cap. Flow
-$32.4M
Cap. Flow %
-39.71%
Top 10 Hldgs %
71.77%
Holding
105
New
34
Increased
2
Reduced
37
Closed
24

Top Buys

Rank Stock Value
1
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
+$1.6M
2
BWAY
Brainsway
BWAY
+$568K
3
AMZN icon
Amazon
AMZN
+$466K
4
JPM icon
JPMorgan Chase
JPM
+$452K
5
BABA icon
Alibaba
BABA
+$380K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$12.1M
2
SEDG icon
SolarEdge
SEDG
+$6.42M
3
VTRS icon
Viatris
VTRS
+$5.67M
4
DK icon
Delek US
DK
+$1.35M
5
RY icon
Royal Bank of Canada
RY
+$605K

Sector Composition

Rank Sector Weight
1 Technology 58.02%
2 Energy 11.29%
3 Healthcare 7.68%
4 Communication Services 6%
5 Financials 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADP icon
51
Automatic Data Processing
ADP
$107B
$289K 0.35%
+1,750
New +$284K
PAYX icon
52
Paychex
PAYX
$41.7B
$288K 0.35%
3,500
-2,100
-38% -$177K
PNC icon
53
PNC Financial Services
PNC
$102B
$288K 0.35%
+2,100
New +$278K
BNY
54
Bank of New York Mellon
BNY
$108B
$287K 0.35%
+6,500
New +$305K
ELV icon
55
Elevance Health
ELV
$83.3B
$282K 0.35%
1,000
-1,000
-50% -$273K
AMGN icon
56
Amgen
AMGN
$222B
$276K 0.34%
+1,500
New +$269K
COP icon
57
ConocoPhillips
COP
$142B
$268K 0.33%
+4,400
New +$274K
EMN icon
58
Eastman Chemical
EMN
$8.35B
$265K 0.32%
3,400
-2,100
-38% -$160K
HSBC icon
59
HSBC
HSBC
$351B
$263K 0.32%
6,300
-7,361
-54% -$308K
TSM icon
60
TSMC
TSM
$2.2T
$259K 0.32%
+6,600
New +$272K
TSN icon
61
Tyson Foods
TSN
$20.6B
$258K 0.32%
3,200
-3,800
-54% -$293K
KO icon
62
Coca-Cola
KO
$372B
$255K 0.31%
+5,000
New +$245K
SBUX icon
63
Starbucks
SBUX
$120B
$251K 0.31%
+3,000
New +$235K
CB icon
64
Chubb
CB
$135B
$250K 0.31%
1,700
-1,800
-51% -$260K
MCD icon
65
McDonald's
MCD
$192B
$249K 0.31%
+1,200
New +$238K
NEE icon
66
NextEra Energy
NEE
$180B
$246K 0.3%
+4,800
New +$236K
CDW icon
67
CDW
CDW
$16.9B
$244K 0.3%
2,200
-2,200
-50% -$231K
HON icon
68
Honeywell
HON
$79.5B
$244K 0.3%
+1,485
New +$236K
AZO icon
69
AutoZone
AZO
$49.7B
$242K 0.3%
220
-230
-51% -$242K
ACN icon
70
Accenture
ACN
$104B
$240K 0.29%
1,300
-1,300
-50% -$233K
PGR icon
71
Progressive
PGR
$124B
$240K 0.29%
3,000
-3,900
-57% -$302K
MRSH
72
Marsh
MRSH
$91.4B
$239K 0.29%
+2,400
New +$230K
SO icon
73
Southern Company
SO
$107B
$238K 0.29%
+4,300
New +$230K
CDK
74
DELISTED
CDK Global, Inc.
CDK
$237K 0.29%
+4,800
New +$257K
DUK icon
75
Duke Energy
DUK
$96.2B
$229K 0.28%
2,600
-5,100
-66% -$451K
1 2
3
4 5

Similar funds

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return

Noked Israel's Q2 2019 Portfolio in Review

As of Q2 2019, Noked Israel held 105 positions worth $81.6M, down 15% from $95.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Noked Israel withdrew a net $32.4M in Q2 2019, closing 24 positions and reducing 37 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 39% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Noked Israel opened a new position in Gamida Cell Ltd. Ordinary Shares worth $1.03M.

  • Noked Israel's largest Q2 2019 buy was Gamida Cell Ltd. Ordinary Shares: 203,748 shares worth $1.03M.
  • Noked Israel added most to Alphabet (Google) Class A in Q2 2019, an estimated $174K increase.
  • Noked Israel's biggest Q2 2019 reduction was SolarEdge, cutting an estimated $6.42M.
  • Noked Israel fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $12.1M.
  • Noked Israel's ten largest holdings make up 72% of its $81.6M portfolio in Q2 2019.
  • Noked Israel opened 34 new positions and closed 24 in Q2 2019.
  • Noked Israel's portfolio value fell 15% quarter-over-quarter to $81.6M.

Based on Noked Israel's 13F filing for Q2 2019, filed 15 Aug 2019.